Christine Rollier
#186,332
Most Influential Person Now
French-British immunologist
Christine Rollier's AcademicInfluence.com Rankings
Christine Rollierbiology Degrees
Biology
#15808
World Rank
#19872
Historical Rank
Immunology
#1098
World Rank
#1127
Historical Rank
Download Badge
Biology
Christine Rollier's Degrees
- Bachelors Biology Université Paris Cité
- Masters Immunology Université Paris Cité
- PhD Immunology University of Oxford
Similar Degrees You Can Earn
Why Is Christine Rollier Influential?
(Suggest an Edit or Addition)According to Wikipedia, Christine Rollier is a French-British immunologist who is a professor at the University of Surrey. She focusses on the development of viral vector vaccines to treat infectious diseases. In particular, Rollier has focussed on the development of vaccinations to eliminate the plague.
Christine Rollier's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK (2020) (3297)
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (2020) (1480)
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial (2020) (1079)
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials (2021) (812)
- T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial (2020) (367)
- Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison (2020) (331)
- Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (2020) (228)
- Viral vectors as vaccine platforms: deployment in sight. (2011) (202)
- Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) (2021) (150)
- Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass (2010) (146)
- Viral vectors as vaccine platforms: from immunogenicity to impact. (2016) (141)
- Upregulation of Indoleamine 2,3-Dioxygenase in Hepatitis C Virus Infection (2007) (125)
- CD8+ T Effector Memory Cells Protect against Liver-Stage Malaria (2011) (124)
- A blood atlas of COVID-19 defines hallmarks of disease severity and specificity (2021) (112)
- Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein. (1999) (104)
- Vaccine‐induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD‐1 and chronicity (2007) (97)
- Control of Heterologous Hepatitis C Virus Infection in Chimpanzees Is Associated with the Quality of Vaccine-Induced Peripheral T-Helper Immune Response (2004) (95)
- Natural mutations in a Staphylococcus aureus virulence regulator attenuate cytotoxicity but permit bacteremia and abscess formation (2016) (79)
- Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates. (2010) (77)
- Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment (2003) (73)
- Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates. (2008) (61)
- MAIT cell activation augments adenovirus vector vaccine immunogenicity (2020) (58)
- Progress in DNA vaccine for prophylaxis and therapy of hepatitis B. (2003) (54)
- Fusion of the Mycobacterium tuberculosis Antigen 85A to an Oligomerization Domain Enhances Its Immunogenicity in Both Mice and Non-Human Primates (2012) (49)
- Clearance of Genotype 1b Hepatitis C Virus in Chimpanzees in the Presence of Vaccine-Induced E1-Neutralizing Antibodies (2011) (47)
- Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting. (2005) (43)
- Mixed Vector Immunization With Recombinant Adenovirus and MVA Can Improve Vaccine Efficacy While Decreasing Antivector Immunity (2012) (41)
- Maternally Transferred Antibodies from DNA-Immunized Avians Protect Offspring against Hepadnavirus Infection (2000) (40)
- A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial (2015) (36)
- Early life humoral response of ducks to DNA immunization against hepadnavirus large envelope protein. (2000) (29)
- Residues Critical for Duck Hepatitis B Virus Neutralization Are Involved in Host Cell Interaction (1999) (28)
- Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B Meningococci (2016) (24)
- Expression of tak1 and tram induces synergistic pro-inflammatory signalling and adjuvants DNA vaccines. (2009) (24)
- Identification of Antigenic Regions of Duck Hepatitis B Virus Core Protein with Antibodies Elicited by DNA Immunization and Chronic Infection (2004) (23)
- Priorities for developing respiratory syncytial virus vaccines in different target populations (2020) (21)
- The capsular group B meningococcal vaccine, 4CMenB: clinical experience and potential efficacy (2015) (19)
- Neisseria meningitidis Native Outer Membrane Vesicles Containing Different Lipopolysaccharide Glycoforms as Adjuvants for Meningococcal and Nonmeningococcal Antigens (2013) (17)
- Irradiated wild-type and Spa mutant Staphylococcus aureus induce anti-S. aureus immune responses in mice which do not protect against subsequent intravenous challenge. (2013) (14)
- Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria (2017) (13)
- Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region (2018) (11)
- Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses (2016) (11)
- Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis (2019) (11)
- Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (2021) (10)
- Population variation in anti-S. aureus IgG isotypes influences surface protein A mediated immune subversion. (2016) (9)
- Needle-Free Dermal Delivery of a Diphtheria Toxin CRM197 Mutant on Potassium-Doped Hydroxyapatite Microparticles (2015) (8)
- Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines (2021) (8)
- Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule (2020) (7)
- Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine (2017) (7)
- T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates (2016) (7)
- Development of persistent gastrointestinal S. aureus carriage in mice (2017) (7)
- Comparative transcriptomics between species attributes reactogenicity pathways induced by the capsular group B meningococcal vaccine, 4CMenB, to the membrane-bound endotoxin of its outer membrane vesicle component (2019) (6)
- Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles (2016) (5)
- Activation of MAIT cells plays a critical role in viral vector vaccine immunogenicity (2019) (4)
- Rapid travel to a Zika vaccine: are we heading towards success or more questions? (2018) (4)
- Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine (2020) (4)
- Recent advances in lipopolysaccharide-based glycoconjugate vaccines (2021) (4)
- Adjuvant Effects Elicited by Novel Oligosaccharide Variants of Detoxified Meningococcal Lipopolysaccharides on Neisseria meningitidis Recombinant PorA Protein: A Comparison in Mice (2014) (4)
- Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease. (2019) (3)
- Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19 (2022) (3)
- The effect of a single 4CMenB vaccine booster in young people more than ten years after infant immunisation: protocol of an exploratory immunogenicity study (2019) (2)
- Viral Vectors Expressing Group B Meningococcal Outer Membrane Proteins Induce Strong Antibody Responses but Fail to Induce Functional Bactericidal Activity in Mice. (2022) (2)
- Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial (2022) (2)
- The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens (2017) (2)
- Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial. (2022) (2)
- MRI Based Localisation and Quantification of Abscesses following Experimental S. aureus Intravenous Challenge: Application to Vaccine Evaluation (2016) (2)
- Adenovirus vectors activate Vδ2+ γδT cells in a type I interferon‐, TNF‐, and IL‐18‐dependent manner (2021) (2)
- Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007. (2018) (2)
- Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial (2021) (2)
- Publisher Correction: Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria (2019) (1)
- Alcock Vectors at Supraphysiological Temperatures in Carbohydrate Glass Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine (2010) (1)
- Vaccination of chimpanzees with a multicomponent DNA-protein prime-boost regimen provides an enhanced recovery following heterologous HCV challenge. (2001) (1)
- Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen (2021) (1)
- Heterogeneous early immune responses to the S. aureus EapH2 antigen induced by gastrointestinal tract colonisation impact the response to subsequent vaccination. (2019) (1)
- Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity (2022) (1)
- Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule (2020) (0)
- DNA immunization for production in egg factory of protective antibodies against hepadnavirus infection (1999) (0)
- Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines. (2023) (0)
- Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria (2017) (0)
- Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus (2022) (0)
- The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens (2017) (0)
- New vectored vaccines for malaria. (2008) (0)
- Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation. (2022) (0)
- CD8(+) T effector memory cells are a correlate of protection against liver-stage malaria (2010) (0)
- against Liver-Stage Malaria T Effector Memory Cells Protect + CD8 (0)
- Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus (2022) (0)
- Development of persistent gastrointestinal S. aureus carriage in mice (2017) (0)
- Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region (2018) (0)
- Fusion of the Mycobacteriumtuberculosis Antigen 85A to an Oligomerization Domain Enhances Its Immunogenicity in Both Mice and Non-Human Primates (2012) (0)
- Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen (2021) (0)
- DNA immunization for identification and localization of antigenic regions on duck hepatitis B virus core protein. (2001) (0)
- Publisher Correction: Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria (2019) (0)
- Regulatory T cell profiles in patients with N-methyl-ᴅ-aspartate receptor-antibody encephalitis (2023) (0)
- Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis (2019) (0)
- Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults (2023) (0)
This paper list is powered by the following services:
Other Resources About Christine Rollier
What Schools Are Affiliated With Christine Rollier?
Christine Rollier is affiliated with the following schools:
